JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M209386200 on October 22, 2002

J. Biol. Chem., Vol. 277, Issue 51, 49638-49643, December 20, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/51/49638    most recent
M209386200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pang, Q.
Right arrow Articles by Bagby, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pang, Q.
Right arrow Articles by Bagby, G. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Anti-apoptotic Function of Hsp70 in the Interferon-inducible Double-stranded RNA-dependent Protein Kinase-mediated Death Signaling Pathway Requires the Fanconi Anemia Protein, FANCC*

Qishen PangDagger §, Tracy A. ChristiansonDagger , Winifred KeebleDagger , Tara KoretskyDagger , and Grover C. BagbyDagger §

From the Dagger  OHSU Cancer Institute, Department of Medicine and Molecular and Medical Genetics, Oregon Health and Science University and § Veterans Affairs Medical Center, Portland, Oregon 97201

Proteins encoded by five of the six known Fanconi anemia (FA) genes form a heteromeric complex that facilitates repair of DNA damage induced by cross-linking agents. A certain number of these proteins, notably FANCC, also function independently to modulate apoptotic signaling, at least in part, by suppressing ground state activation of the pro-apoptotic interferon-inducible double-stranded RNA-dependent protein kinase (PKR). Because certain FANCC mutations interdict its anti-apoptotic function without interfering with the capacity of FANCC to participate functionally in the FA multimeric complex, we suspected that FANCC enhances cell survival independent of its participation in the complex. By investigating this function in both mammalian cells and in yeast, an organism with no FA orthologs, we show that FANCC inhibited the kinase activity of PKR both in vivo and in vitro, and this effect depended upon a physical interaction between FANCC and Hsp70 but not on interactions of FANCC with other Fanconi proteins. Hsp70, FANCC, and PKR form a ternary complex in lymphoblasts and in yeast expressing PKR. We conclude that Hsp70 requires the cooperation of FANCC to suppress PKR activity and support survival of hematopoietic cells and that FANCC does not require the multimeric FA complex to exert this function.


* This work was supported in part by National Institutes of Health Grant HL48546 (to G. C. B.) and a grant from the Northwest Health Foundation (to Q. P.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: OHSU Cancer Institute, CR145, Oregon Health Sciences University, Portland, OR 97201. E-mail: grover@ohsu.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
D. P. Sejas, R. Rani, Y. Qiu, X. Zhang, S. R. Fagerlie, H. Nakano, D. A. Williams, and Q. Pang
Inflammatory Reactive Oxygen Species-Mediated Hemopoietic Suppression in Fancc-Deficient Mice
J. Immunol., April 15, 2007; 178(8): 5277 - 5287.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
E. Schmitt, M. Gehrmann, M. Brunet, G. Multhoff, and C. Garrido
Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy
J. Leukoc. Biol., January 1, 2007; 81(1): 15 - 27.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
M. A. Garcia, J. Gil, I. Ventoso, S. Guerra, E. Domingo, C. Rivas, and M. Esteban
Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action
Microbiol. Mol. Biol. Rev., December 1, 2006; 70(4): 1032 - 1060.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
S. S. Mukhopadhyay, K. S. Leung, M. J. Hicks, P. J. Hastings, H. Youssoufian, and S. E. Plon
Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia
J. Cell Biol., October 23, 2006; 175(2): 225 - 235.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. L. Bennett, W. L. Blalock, D. M. Abtahi, Y. Pan, S. A. Moyer, and W. S. May
RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection
Blood, August 1, 2006; 108(3): 821 - 829.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Guerra, L. A. Lopez-Fernandez, M. A. Garcia, A. Zaballos, and M. Esteban
Human Gene Profiling in Response to the Active Protein Kinase, Interferon-induced Serine/threonine Protein Kinase (PKR), in Infected Cells: INVOLVEMENT OF THE TRANSCRIPTION FACTOR ATF-3 IN PKR-INDUCED APOPTOSIS
J. Biol. Chem., July 7, 2006; 281(27): 18734 - 18745.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. C. Bagby
The less-traveled Fanconi road
Blood, June 1, 2006; 107(11): 4196 - 4197.
[Full Text] [PDF]


Home page
BloodHome page
T. Taniguchi and A. D. D'Andrea
Molecular pathogenesis of Fanconi anemia: recent progress
Blood, June 1, 2006; 107(11): 4223 - 4233.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Bijangi-Vishehsaraei, M. R. Saadatzadeh, A. Werne, K. A. W. McKenzie, R. Kapur, H. Ichijo, and L. S. Haneline
Enhanced TNF-{alpha}-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1
Blood, December 15, 2005; 106(13): 4124 - 4130.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Q. Chen, P. C. Van der Sluis, D. Boulware, L. A. Hazlehurst, and W. S. Dalton
The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells
Blood, July 15, 2005; 106(2): 698 - 705.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Li, M. M. Le Beau, S. Ciccone, F.-C. Yang, B. Freie, S. Chen, J. Yuan, P. Hong, A. Orazi, L. S. Haneline, et al.
Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy
Blood, May 1, 2005; 105(9): 3465 - 3471.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Yamashita, W. Kamitani, H. Yanai, N. Ohtaki, Y. Watanabe, B.-J. Lee, S. Tsuji, K. Ikuta, and K. Tomonaga
Persistent Borna Disease Virus Infection Confers Instability of HSP70 mRNA in Glial Cells during Heat Stress
J. Virol., February 15, 2005; 79(4): 2033 - 2041.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Zhang, J. Li, D. P. Sejas, K. R. Rathbun, G. C. Bagby, and Q. Pang
The Fanconi Anemia Proteins Functionally Interact with the Protein Kinase Regulated by RNA (PKR)
J. Biol. Chem., October 15, 2004; 279(42): 43910 - 43919.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. R. Fagerlie, T. Koretsky, B. Torok-Storb, and G. C. Bagby
Impaired Type I IFN-Induced Jak/STAT Signaling in FA-C Cells and Abnormal CD4+ Th Cell Subsets in Fancc-/- Mice
J. Immunol., September 15, 2004; 173(6): 3863 - 3870.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Saadatzadeh, K. Bijangi-Vishehsaraei, P. Hong, H. Bergmann, and L. S. Haneline
Oxidant Hypersensitivity of Fanconi Anemia Type C-deficient Cells Is Dependent on a Redox-regulated Apoptotic Pathway
J. Biol. Chem., April 16, 2004; 279(16): 16805 - 16812.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Pipaon, J. A. Casado, J. A. Bueren, and J. L. Fernandez-Luna
Jun N-terminal kinase activity and early growth-response factor-1 gene expression are down-regulated in Fanconi anemia group A lymphoblasts
Blood, January 1, 2004; 103(1): 128 - 132.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Freie, X. Li, S. L. M. Ciccone, K. Nawa, S. Cooper, C. Vogelweid, L. Schantz, L. S. Haneline, A. Orazi, H. E. Broxmeyer, et al.
Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis
Blood, December 1, 2003; 102(12): 4146 - 4152.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Pang, T. A. Christianson, T. Koretsky, H. Carlson, L. David, W. Keeble, G. R. Faulkner, A. Speckhart, and G. C. Bagby
Nucleophosmin Interacts with and Inhibits the Catalytic Function of Eukaryotic Initiation Factor 2 Kinase PKR
J. Biol. Chem., October 24, 2003; 278(43): 41709 - 41717.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.